11 – 20 of 90
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
A novel COL1A1 variant in a family with clinical features of hypermobile Ehlers-Danlos syndrome that proved to be a COL1-related overlap disorder
- Contribution to journal › Article
-
Mark
Clinical and Molecular Spectrum Associated with COL6A3 c.7447A>G p.(Lys2483Glu) Variant : Elucidating its Role in Collagen VI-related Myopathies
- Contribution to journal › Article
-
Mark
Merosin deficient congenital muscular dystrophy type 1A : An international workshop on the road to therapy 15-17 November 2019, Maastricht, the Netherlands
- Contribution to journal › Article
- 2020
-
Mark
Antioxidants reduce muscular dystrophy in the dy2J/dy2J mouse model of laminin α2 chain-deficient muscular dystrophy
- Contribution to journal › Article
-
Mark
A Family of Laminin α2 Chain-Deficient Mouse Mutants : Advancing the Research on LAMA2-CMD
- Contribution to journal › Scientific review
- 2019
-
Mark
A mutation-independent approach for muscular dystrophy via upregulation of a modifier gene
- Contribution to journal › Letter
-
Mark
Effects of N-acetyl-L-cysteine and vitamin E on congenital muscular dystrophy type 1A disease progression in mice
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2018
-
Mark
Laminin α1 reduces muscular dystrophy in dy2Jmice
- Contribution to journal › Article
-
Mark
Effects of metformin on congenital muscular dystrophy type 1A disease progression in mice: a gender impact study
(2018) In Scientific Reports
- Contribution to journal › Article
-
Mark
Potential therapies and biomarkers for LAMA2-CMD. Does the microRNA hype deliver?
- Thesis › Doctoral thesis (compilation)
